ENTITY

Stemline Therapeutics (STML US)

Health Care • United States

Stemline Therapeutics Inc. provides biopharmaceutical services. The Company offers research, discovery, and development of novel compounds that target cancer stem cells.

Refresh

No events found

We’ll display events we find for Stemline Therapeutics here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00